Myovant Sciences Ltd. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2016 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Myovant Sciences Ltd. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2016 to Q1 2022.
  • Myovant Sciences Ltd. Deferred Tax Assets, Valuation Allowance for the quarter ending March 31, 2022 was $244M, a 17.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 $244M +$36.3M +17.5% Mar 31, 2022 10-K 2022-05-11
Q1 2021 $208M +$50.3M +32% Mar 31, 2021 10-K 2022-05-11
Q1 2020 $158M +$65.2M +70.6% Mar 31, 2020 10-K 2021-05-11
Q1 2019 $92.3M +$71M +332% Mar 31, 2019 10-K 2020-05-18
Q1 2018 $21.4M +$14M +189% Mar 31, 2018 10-K 2019-05-24
Q1 2017 $7.4M +$7.4M Mar 31, 2017 10-K 2018-06-07
Q1 2016 $0 Mar 31, 2016 10-K 2017-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.